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Abstract
Purpose Quantitative estimates of dopamine transporter avail-
ability, determined with [123I]FP-CIT SPECT, depend on the
SPECT equipment, including both hardware and
(reconstruction) software, which limits their use in multicentre
research and clinical routine. This study tested a dedicated re-
construction algorithm for its ability to reduce camera-specific
intersubject variability in [123I]FP-CIT SPECT. The secondary
aimwas to evaluate binding in whole brain (excluding striatum)
as a reference for quantitative analysis.
Methods Of 73 healthy subjects from the European Normal
Control Database of [123I]FP-CIT recruited at six centres, 70
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aged between 20 and 82 years were included. SPECT images
were reconstructed using the QSPECT software package
which provides fully automated detection of the outer contour
of the head, camera-specific correction for scatter and septal
penetration by transmission-dependent convolution subtrac-
tion, iterative OSEM reconstruction including attenuation cor-
rection, and camera-specific Bto kBq/ml^ calibration. LINK
and HERMES reconstruction were used for head-to-head
comparison. The specific striatal [123I]FP-CIT binding ratio
(SBR) was computed using the Southampton method with
binding in the whole brain, occipital cortex or cerebellum as
the reference. The correlation between SBR and age was used
as the primary quality measure.
Results The fraction of SBR variability explained by age was
highest (1) with QSPECT, independently of the reference re-
gion, and (2) with whole brain as the reference, independently
of the reconstruction algorithm.
Conclusion QSPECT reconstruction appears to be useful for
reduction of camera-specific intersubject variability of
[123I]FP-CIT SPECT in multisite and single-site multicamera
settings. Whole brain excluding striatal binding as the refer-
ence provides more stable quantitative estimates than occipital
or cerebellar binding.
Keywords QSPECT . Dopamine transporter scintigraphy .
[123I]FP-CIT . Specific binding ratio . Age . ENC-DAT
Introduction
SPECT with the ligand N-ω-f luoropropyl-2β-car
bomethoxy-3β-(4-[123I]iodophenyl)nortropane ([123I]FP-
CIT, FP-CIT) for the presynaptic dopamine transporter
(DAT) is widely used in the diagnostic process of parkinso-
nian syndromes and for the differentiation between
Alzheimer’s disease and dementia with Lewy bodies [1–5].
The interpretation of DAT SPECT is based on visual evalua-
tion of the images which can be supported by quantitative
analysis [6–12]. In some studies, quantitative analysis provid-
ed better diagnostic accuracy than visual rating. For example,
O’Brien et al., evaluating FP-CIT SPECT for the differential
diagnosis of dementia with Lewy bodies and Alzheimer’s dis-
ease, found that quantitative analysis resulted in considerably
better specificity than visual rating (94 % vs. 85 %) with equal
sensitivity (78 %), although visual assessment was undertaken
by five independent, trained raters [13]. This underlines the
potential of quantitative analysis in FP-CIT SPECT.
However, in this single-centre study by O’Brien et al. all
participants were scanned with the same SPECT camera and
according to the same acquisition and reconstruction protocol
[13]. It is well known that the SPECT equipment, including
both hardware and software, has a significant impact on the
reconstructed images. For 99mTc-labelled tracers the impact of
camera hardware is rather small [14], so that the main contri-
bution to camera-specific variability in 99mTc SPECT studies
is due to vendor-specific differences in the reconstruction soft-
ware. SPECT with 123I-labelled tracers is sensitive also to
hardware due to penetration of high-energy photons.
Camera-specific variability in FP-CIT SPECT binding ratios
has been demonstrated by Tossici-Bolt et al. who performed
123I SPECT imaging of the same striatal phantom in 15
European centres on 17 SPECT systems and found a random
variability in the quantitative analysis among the SPECT sys-
tems of up to 13.9 % [15].
The impact of SPECT system dependence on diagnostic
accuracy is most likely more pronounced in quantitative anal-
ysis than in visual rating. This might explain the fact that, for
example, the phase III multicentre trial of FP-CIT SPECT in
dementia with Lewy bodies did not demonstrate diagnostic
accuracy of quantitative analysis but of visual rating only [16].
The system dependence of quantitative analysis of FP-CIT
SPECT can be reduced by applying the same reconstruction
algorithm to scatter-compensated and penetration-compensated
projection data, the latter being considered independent of the
SPECTcamera. This approach has been successfully implement-
ed in a Europeanmulticentre study initiated by theNeuroimaging
Committee of the European Association of Nuclear Medicine to
generate a database of FP-CIT SPECT in healthy controls
(ENC-DAT) [17]. The aim of this initiative was to provide refer-
ence images and values for quantitative analyses over a wide age
range from young adolescence (20 years) to old age (90 years).
SPECT images were reconstructed by a core laboratory using a
LINK or HERMES workstation (see section Image
reconstruction).
Analyses of ENC-DAT data have shown an age-related
decline in the specific binding ratio (SBR) in the striatum
and its subregions [17, 18]. The age effect was statistically
highly significant, not least due to the large age range and
the large sample size. However, there was strikingly large
intersubject variability in SBR which could not be explained
by age or any of the other covariates considered (gender,
handedness, body mass index, and season and time of day
when the FP-CIT SPECTwas performed) [17, 18]. A consid-
erable fraction of this still unexplained intersubject variability
might be related to camera-specific intersite variability in the
imaging process rather than being actual physiological vari-
ability in DAT availability, despite the efforts to minimize
intersite variability.
The primary aim of the present study therefore was to re-
duce nonphysiological intrasite and intersite variability in
FP-CIT SPECT scans in the ENC-DAT by the use of the
reconstruction algorithm ‘QSPECT’, which is expected to be
particularly useful in multisite settings. QSPECT is an OSEM
reconstruction algorithm with (1) fully automated detection of
the outer contour of the head for iterative reconstruction in-
cluding attenuation correction, (2) correction for scatter and
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septal penetration by transmission-dependent convolution
subtraction (TDCS), and (3) Bto kBq/ml^ calibration of voxel
intensities [19–21]. QSPECT explicitly accounts for the cam-
era with which the SPECT data were acquired by using
camera-specific calibration factors for correction of scatter
and septal penetration as well as for Bto kBq/ml^ calibration.
These camera-specific factors were measured previously and
are available in the QSPECT software. QSPECT has been
successfully used in multicentre studies of brain perfusion
SPECTwith [123I]iodoamphetamine [22, 23].
We hypothesized that the use of QSPECT would reduce
nonphysiological intersubject variability in quantitative
measures of DAT availability in the ENC-DAT data com-
pared to previous analyses. To test this hypothesis, the
correlation between SBR and age was used as the primary
quality measure (stronger correlation indicating a reduc-
tion in nonphysiological variability). A secondary aim of
the study was to evaluate different reference regions for
estimation of nonspecific FP-CIT binding with respect to
their impact on the random error in the quantitative
analysis.
Materials and methods
Subjects
Data from 73 healthy subjects recruited at six different centres
were obtained from the EuropeanNormal Control Database of
FP-CIT (ENC-DAT) [15, 17]. The centres were selected (1) to
encompass a spectrum of SPECT systems currently in clinical
use and (2) to include only data from SPECT cameras for
which the camera-specific factors for correction of scatter
and septal penetration were available in QSPECT (see
section Image reconstruction). Inclusion and exclusion criteria
of the ENC-DAT study have been described previously [17].
Three subjects from one centre (Amsterdam) were excluded
from the present study because of serious truncation of their
projection data. Details of the remaining 70 subjects are given
in Table 1. Handedness was assessed using the Edinburgh
Inventory [24]. However, handedness was not taken into ac-
count in the analyses of the present study because only seven
subjects (10 %) were left-handed.
SPECT imaging
SPECT imaging was performed with six different cameras of
various model types from two different manufacturers
(Table 1). All cameras were equipped with low-energy
high-resolution (LEHR) parallel-hole collimators. The cam-
eras were certified prior to the start of subject recruitment.
Their stability during the recruitment phase was verified by
a rigorous quality control protocol [17]. Subject preparation Ta
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and acquisition protocol have been described in detail previ-
ously [17]. In some subjects, two SPECTscans were acquired,
one at 3 h the other at 4 h after injection. The present study
included the 3-h scans except for the subjects from
Amsterdam. In Amsterdam, a brain-dedicated SPECTsystem,
Neurofocus, was used at 3 h after injection and a Siemens
ECAM was used at 4 h after injection. The scans acquired
on the ECAM at 4 h after injection were used in the present
study, because the reconstruction method to be tested,
QSPECT, did not allow processing of raw data acquired on
the Neurofocus system, but can be applied to projection data
from conventional SPECT systems only.
Image reconstruction
Transverse SPECT images generated from projection data
using three different software packages were used in the pres-
ent study. First, images reconstructed on a Link workstation
with MAPS-10000 software (Link Medical) were obtained
from the ENC-DAT (LINK method). LINK reconstruction
was performed on projection data already corrected for scatter
and septal penetration using the triple energy window tech-
nique [25, 26]. LINK reconstruction employed the original
OSEM code by R. Larkin (Macquarie University code BR
v2005.200 Mar 7 2005^ [27]) with 10 iterations/10 subsets
and 12 iterations/8 subsets for raw data with 120 and 128
projections, respectively [15, 17]. OSEM parameter settings
differed from the default with respect to BStart-Image^ and
BDivRecon^ as described previously [15]. Attenuation correc-
tion was performed iteratively based on ellipses of variable
size with uniform (narrow beam) attenuation coefficient
μ=0.143 cm−1 fed into OSEM [15]. The ellipses were defined
automatically by contour finding based on background counts
in the skull and were checked for accurate delineation of the
head by visual inspection in each individual scan. A
Butterworth filter with cut-off 0.50 cm−1 and order ten was
used for three-dimensional postfiltering.
Second, reconstruction was performed on a Hermes
workstation (Hermes Medical Solutions, Stockholm;
HERMES method). Raw data were corrected for scatter
and septal penetration using the same triple energy win-
dow technique as in the LINK method [25, 26].
Attenuation correction was performed by the iterative
Chang technique using semiautomatically defined ellipti-
cal head outlines and a uniform (narrow beam) attenuation
coefficient of μ= 0.143 cm−1. HERMES used the same
version of Larkin’s OSEM code [27] as LINK, but with
default settings for all parameters including BStart-Image^
and BDivRecon^. There were 10 iterations/10 subsets and
12 iterations/8 subsets for raw data with 120 and 128
projections, respectively. A Butterworth filter with
cut -of f 0 .50 cm− 1 and order ten was used for
three-dimensional postfiltering [17].
Third, images were reconstructed using the QSPECT
software package (QSPECT method). QSPECT first gen-
erates a uniform attenuation μ map by automated detec-
tion of the outer contour of the head. The latter is based
on fitting sine-waves to the edges of the head in the
sinogram representation of the projection data prior to
scatter correction. Sinograms without scatter correction
are used for this purpose, because photons scattered in
the skull (or the scalp) are incorrectly located to the skull
(or the scalp) and therefore tend to accentuate the edges of
the head. This stabilizes the fit of the head contour and
therefore allows more irregular shapes than ellipses in
image space. QSPECT saves the attenuation μ map so that
it can be checked for correct head delineation by visual
inspection.
For scatter correction, QSPECT applies the TDCS method
to generate scatter-free projection data on a geometric mean
(GM) basis [28–30]. Geometric averaging of opposed projec-
tions halves the number of projections. Scatter correction is
extended to account also for septal photon penetration [20],
which is non-negligible in the case of 123I particularly with
low-energy (e.g. LEHR) collimators. Collimator-specific sep-
tal penetration factors were used, which have been measured
previously. ‘QSPECT OSEM’ reconstruction was applied to
the GM projections with 4 iterations/8 subsets (slice thickness
2 mm, pitch 1). QSPECTOSEM is an OSEM implementation
independent of the Macquarie code. Differences between the
two OSEM implementations include the collimator aperture
modelling, the scatter function, and the offset to account for
down scatter [20, 29]. QSPECT performs attenuation correc-
tion iteratively during reconstruction. A uniform attenuation
map with μ=0.160 cm−1 inside the head contour was used as
this value has been shown to provide the best agreement with
attenuation correction based on transmission scanning in hu-
man brain [20]. A three-dimensional isotropic gaussian kernel
with 7mm full-width at half-maximum (FWHM)was used for
postfiltering. This filter was selected based on a small pilot
study using visual scoring of image quality by an experienced
reader. Finally, reconstructed images were scaled by a previ-
ously measured camera-specific Bto kBq/ml^ calibration fac-
tor and taking into account voxel size, duration of the acqui-
sition and the number of projections. This resulted in quanti-
tative QSPECT images with voxel intensities representing the
radioactivity concentration in kilobecquerels per millilitre [22,
23]. It should be noted that the calibration to BkBq/ml^ did not
affect the results of the present study, since any global calibra-
tion factor cancels in the computation of the SBR (see section
Quantitative analysis).
Quantitative analysis
Regions of interest (ROIs) for the left and right striatum,
whole brain, occipital lobe and cerebellum were positioned
1326 Eur J Nucl Med Mol Imaging (2016) 43:1323–1336
manually for each individual subject. This individual ROI set
could be used without any changes in all three SPECT images
of the subject, i.e. with each reconstruction method, since the
reconstructed field of view and voxel size (2.398 mm) were
exactly the same for all reconstruction methods.
Coregistration and/or reslicing of one image to another, which
can introduce some bias due to additional smoothing during
interpolation, or manual adaptation of the ROIs between the
different reconstruction methods were not required. ROIs for
the left and right striatum, whole brain and occipital lobe were
defined in 18 consecutive transverse slices, left and right stri-
atum by ‘big’ rectangles, and whole brain and occipital lobe
by ellipses (Fig. 1). The volume of the unilateral striatum ROI
was 127.6 ml. The cerebellum ROI was defined in six consec-
utive transverse slices through the cerebellum using an ellipse
(Fig. 1). The number of slices was reduced if part of the cer-
ebellum had not been within the field of view of the SPECT
acquisition in order to avoid underestimation of the
nondisplaceable FP-CIT binding by Bair voxels^ in the cere-
bellar ROI.
The SBR was computed according to the Southampton
method developed by Fleming et al. to reduce the impact of
recovery and partial volume effects [31]. More precisely, the
SBR was computed according to the formulas:
SBR ¼ SUSI=VS ; ð1Þ
where VS is the volume of the striatum (assumed to be 11.2 ml),
and the specific uptake size index (SUSI) is obtained as:
SUSI ¼ T – CR* Vð Þ=CR ¼ T=CR−V ð2Þ
where T is the total activity in the striatal ROI (in kilobecquerels),
V is the volume of the striatal ROI (in millilitres) and CR is the
FP-CIT activity concentration in the reference region (in
kilobecquerels/millilitre).
The twoROIs for the left and right striatumweremuch bigger
than the actual striatal volume in order to guarantee that all
striatal counts were included (despite spatial ‘smearing’ of
striatal counts due to limited spatial resolution and residual ana-
tomical intersubject variability after stereotactic normalization)
but no other brain structure with FP-CIT binding uptake above
background activity. The striatal ROIs were about the same size
as described in the original paper (Fig. 1 of Fleming et al. [31]).
The mean concentration of FP-CIT in the whole brain, without
the striata, or in the occipital lobe or in the cerebellum was used
as reference CR. Combining each of the three reconstruction
methods (LINK, HERMES, QSPECT) with each of the three
reference regions (whole-brain without striata, occipital lobe,
cerebellum) resulted in a total of nine different SBR values for
(left or right) striatum in each subject.
Camera-specific recovery coefficients for the SBR have
been determined by Tossici-Bolt et al. (ACSC recovery coef-
ficients in Table I of Tossici-Bolt et al. [15]), but for LINK
reconstruction only. As the recovery coefficients are expected
to depend on the details of the reconstruction algorithm, even
if all reconstructions include all corrections (attenuation, scat-
ter and septal penetration), the reported recovery coefficients
were not used in the present study in order to avoid bias to the
disadvantage of HERMES and QSPECT.
Quantitative accuracy of QSPECT
The quantitative accuracy of QSPECT reconstruction, i.e. its
accuracy in reproducing true tracer concentrations in
kilobecquerels per millilitre, has been demonstrated by phan-
tommeasurements in a realistic three-dimensional brain phan-
tom with bone and grey matter structures [32]. In the present
study, the accuracy of QSPECT quantitative analysis in
FP-CIT SPECT was evaluated. For this purpose, projection
data from the striatal phantom measurements provided by
the ENC-DAT [15] were reconstructed using QSPECT with
exactly the same parameter settings as for human data, includ-
ing camera-specific TDCS factors for correction of scatter and
septal penetration, uniform attenuation coefficient
(μ= 0.160 cm−1), number of iterations (four) and subsets
(eight), and gaussian postfiltering (FWHM 7 mm). Phantom
Fig. 1 Regions of interest
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data were included from the same six ENC-DAT centres as in
the analysis of human data. The SBR was obtained according
to the Southampton method with the whole brain (without
striata) as the reference as described above.
Statistical methods
Statistical analyses were performed with SPSS version 21
(IBM Corp., Armonk, NY). The mean of the left and right
SBR was used in all analyses, since the mean showed a
slightly better correlation with age than either the left or
the right striatum separately, or the minimum over both
hemispheres (the smallest left/right asymmetry of striatal
SBR in ENC-DAT subjects, about 2 % larger in the left
hemisphere [17], can be neglected in the present study).
Univariate analysis of variance for repeated measures was
performed to assess the impact of the reconstruction algo-
rithm on the SBR. The effect of age on the SBR was
tested by univariate analysis of variance with SBR as
dependent variable, gender as random factor, and specific
FP-CIT dose (i.e. injected dose in megabecquerels per
kilogram body weight) and age as covariates. The ratio-
nale for including the specific FP-CIT dose in the model
was that the SBR might be underestimated if statistical
image quality is low associated with low specific FP-CIT
dose. All values are presented as means±1 standard devi-
ation of the sample. P values less than 0.05 were consid-
ered statistically significant.
Results
Results of the analysis of ENC-DAT striatal phantom data are
summarized in Fig. 2. The true SBR was reproduced with an
accuracy of ±5 % in almost all cases.
Orthogonal slices of the SPECT image of a representative
human subject are shown in Fig. 3 for the three reconstruction
algorithms. QSPECT reconstruction resulted in more homo-
geneous FP-CIT binding in extrastriatal brain regions com-
pared with LINK and HERMES which both showed some
‘fading out’ of FP-CIT binding towards the edges of the brain
(Fig. 3).
Analysis of variance for repeated measures with the
reconstruction method as the intersubject factor revealed
a highly significant effect of the reconstruction method on
the SBR (F= 584, 137 and 91 for the whole brain without
striata, occipital lobe and cerebellum as reference region,
respectively; p < 0.0005 in all cases). HERMES recon-
struction resulted in the highest SBR values. LINK and
QSPECT resulted in SBR values which were 3.5 ± 5.4 %
and 27.4 ± 8.4 % lower (whole brain without striata as the
reference region). Bland-Altman plots are given in Fig. 4.
The difference between QSPECT and both LINK and
Hermes was more pronounced at large SBR than at low
SBR, suggesting a multiplicative rather than an additive
effect.
Scatter plots of SBR versus age for the different recon-
struction algorithms and reference regions are shown in
Fig. 5. The effect of age on SBR was statistically highly
significant, except when the cerebellum was used as the
reference region (Table 2).
Fig. 2 ENC-DAT striatal phantom data. Southampton SBR (with whole
brain without striata as reference) obtained from QSPECT reconstructed
phantom images (with exactly the same parameter settings as in the
human ENC-DAT data) plotted against the true SBR. The dashed line
is the linear regression line including the data of all sites combined
Fig. 3 Orthogonal slices of the [123I]FP-CIT SPECT image in one
representative subject (a 23-year-old woman) reconstructed with the
three different reconstruction algorithms
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There was no significant effect of specific FP-CIT dose on
SBR. This was confirmed by repeated univariate analysis of
variance without specific FP-CIT dose in the model. For exam-
ple, with QSPECT reconstruction and whole brain without stri-
ata as the reference, the (unstandardized) regression coefficient
for the effect of age on SBR changed to −5.18 (p=0.000; 95 %
CI −6.94, −3.43) from −5.08 (p=0.000; 95 % CI −6.82, −3.33)
when the specific FP-CIT dose was included in the model
(Table 2). The proportion of variance in the SBR explained
by age changed to 0.341 from 0.339 (Table 2).
Concerning the impact of the reconstruction algorithm
on the proportion of variance in the SBR explained by
age, QSPECT reconstruction resulted in the highest pro-
portion independently of the reference region (Table 2).
With the whole brain without striata as the reference re-
gion, for example, age accounted for 33.9 % of the vari-
ance of SBR with QSPECT reconstruction, but only
25.9 % and 22.5 % with LINK and HERMES reconstruc-
tion, respectively. This was confirmed using the regres-
sion coefficients from the univariate analysis of variance
to correct SBR for both age and specific dose (to the
respective means of 53 years and 2.5 MBq/kg, respective-
ly). The coefficient of variance (standard deviation/mean)
of the corrected SBR was lowest for QSPECT (13.8 %)
Fig. 4 aBland-Altman plots of the specific FP-CIT binding ratio over all
subjects for QSPECT versus LINK reconstruction (top), QSPECT versus
Hermes reconstruction (middle) and LINK versus Hermes reconstruction
(bottom) using the whole brain without striata as the reference region in
all cases. b Bland-Altman plots of the specific FP-CIT binding ratio over
all subjects for QSPECT versus LINK reconstruction using the whole
brain without striata (top), occipital lobe (middle) and cerebellum
(bottom) as the reference regions. Left absolute difference versus mean,
right percentage difference (= 100 × difference/mean) versus mean
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and similar for LINK (15.3 %) and HERMES (15.0 %).
The difference in the coefficient of variance was tested
pair-wise for statistical significance using the Pitman test
for comparison of variances in two paired samples [33].
The Pitman test consists of testing for correlation between
the sum and the difference between paired observations
(with a significant correlation indicating a significant dif-
ference in the variances). The nonparametric Spearman
test revealed that the variance with QSPECT was signifi-
cantly different from that with LINK (Spearman’s
rho =−0.247, p= 0.039), but was not significantly differ-
ent from that with HERMES (rho = −0.142, p = 0.242).
The difference in the variances between LINK and
HERMES was also not s ignif icant (rho = 0.062,
p= 0.613).
Concerning the impact of the reconstruction method on the
age-associated decline in SBR, linear regression revealed the
following regression line slopes:
For LINK: SBR=14.8 – 0.606 × age/10
For HERMES: SBR=15.0 – 0.568 × age/10
For QSPECT: SBR=11.8 – 0.519 × age/10
(using the whole brain without striata as the reference
region). Thus, in absolute terms, the slope was steepest
for LINK and flattest for QSPECT. However, the percent-
age loss of SBR, averaged over the age range of the in-
cluded subjects, i.e. 20 – 82 years, was 4.5 %, 4.1 % and
4.8 % with LINK, HERMES and QSPECT, respectively
(note that the percentage loss depends on age, in contrast
Fig. 4 continued.
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to the slope). Thus, in relative terms, the age-associated
decline was most pronounced with QSPECT.
Discussion
The aim of this study was to compare QSPECT, LINK and
HERMES reconstruction with respect to nonphysiological
intersubject variability of the striatal FP-CIT SBR in the
ENC-DAT database. Each of the three reconstruction methods
involves the same steps: first, raw projection data are corrected
for scatter and septal penetration, second, corrected raw data
are reconstructed by OSEM with iterative Chang attenuation
correction, and third, a three-dimensional postfilter is applied.
The most relevant difference between the three methods is in
the correction for scatter and septal penetration in the first step.
LINK and HERMES reconstruction both use the triple energy
window method for this purpose. QSPECT applies the TDCS
method to generate scatter-free projection data on a GM basis.
The latter means that opposed projections are averaged so that
Table 2 Univariate analysis of
variance in the whole sample of
70 subjects with specific binding
ratio as dependent variable,
gender as random factor, and
specific [123I]FP-CIT dose and
age as covariates
LINK HERMES QSPECT
Whole brain without striata
B (×100) −5.93 −5.45 −5.08
p 0.000 0.000 0.000
95 % confidence interval −8.40, −3.47 −7.94, −2.97 −6.82, −3.33
η2 0.259 0.225 0.339
Occipital lobe
B (×100) −5.66 −4.38 −4.82
p 0.000 0.003 0.000
95 % confidence interval −8.53, −2.79 −7.17, −1.60 −6.80, −2.84
η2 0.190 0.130 0.264
Cerebellum
B (×100) −5.88 −3.75 −5.33
p 0.149 0.542 0.046
95 % confidence interval −13.93, +2.16 −15.95, +8.46 −10.55, −0.11
η2 0.031 0.006 0.059
B partial (unstandardized) regression coefficient for the age effect (for convenience, B × 100 rather than B), η2
proportion of variance in SBR explained by age
Fig. 5 Scatter plots of the specific FP-CIT binding ratio (SBR) versus age for the different reconstruction algorithms and reference regions. Note the
difference in the scale of the y-axis for the cerebellum as reference region caused by increased variability and an outlier
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the number of projections is halved. In QSPECT, the TDCS is
adapted to also account for septal photon penetration, using
collimator-specific septal penetration factors which have been
measured previously. The TDCS avoids enhancement of sta-
tistical noise, in contrast to the triple energy window method
which introduces additional noise through the subtraction of
noisy scatter counts measured in additional, rather narrow
energy windows [20]. Building the GM of opposed projec-
tions prior to TDCS provides further noise reduction in
QSPECT.
Another difference lies in the detection of the head contour
for Chang attenuation correction. LINK and HERMES both
use ellipses to fit the outer contour of the head. QSPECT fits
sine-waves to the edges of the head in the sinogram represen-
tation of the projection data prior to scatter correction. This
allows more irregular shapes than ellipses in image space.
Although the difference is small in most patients, it might
not be completely negligible in some patients, in whom the
more irregular shape provides potential for more accurate at-
tenuation correction with QSPECT and, therefore, a reduction
in intersubject variability associated with attenuation correc-
tion errors.
The primary hypothesis of the study was that QSPECT
reduces nonphysiological intersubject variability of the striatal
FP-CIT SBR in the ENC-DAT data compared with LINK and
HERMES. To test this, the correlation between SBR and age
was used as the primary quality measure (stronger correlation
indicating a reduction in nonphysiological variability). In line
with the primary hypothesis, the fraction of variability of the
striatal FP-CIT SBR explained by age was largest with
QSPECT reconstruction. After correction for age (and specific
dose), the coefficient of variance of the SBR with QSPECT
was lower than with both LINK (13.8 % versus 15.3 %,
p=0.039) and HERMES (15.0 %), although the latter differ-
ence did not reach statistical significance (p=0.242). This
suggests that QSPECT reconstruction allows a reduction in
nonphysiological variability in FP-CIT SPECT SBR, includ-
ing camera-specific intercentre variability. We hypothesize
that camera-specific correction for scatter and septal penetra-
tion by QSPECT contributed to this improvement.
Concerning the magnitude of the reconstruction effect on
intersubject variability, age accounted for 33.9 %, 25.9 % and
22.5 % of the SBR variance with QSPECT, LINK and
HERMES, respectively (using the whole brain without striata
as the reference region). The improvement with QSPECT, i.e. a
reduction of unexplained variability of about 10 %, might ap-
pear rather small at first sight. However, the effect is large
enough to immediately catch one’s eye when inspecting the
scatter plots of SBR versus age (Fig. 5). Furthermore, even a
small reduction in errors in quantitative analysis may be rele-
vant, because quantitative analysis might be most useful in
borderline cases with a mild reduction in striatal FP-CIT uptake
in which visual analysis requires a lot of expertise. However, in
these borderline cases the decision is rather sensitive to small
variations in the quantitative parameters, i.e. a small change
might direct the interpretation as either reduced (neurodegener-
ative parkinsonism) or normal (non-neurodegenerative).
Varrone et al. [17] found reduced intersite variability in the
ENC-DAT using camera-specific SBR recovery coefficients
that had been measured with an anthropomorphic striatal
phantom at each of the participating sites [15]. The phantom
measurements demonstrated that there is variability not only
across different SPECT models but also within different sys-
tems of the same model type, perhaps due to differences in
crystal properties. Camera-specific SBR recovery coefficients
were not used in the present study, because they were avail-
able for LINK reconstruction only. Camera-specific TDCS
and Bto kBq/ml^ factors implemented in QSPECT are not
specific to FP-CIT SPECT, but apply to all tracers (labelled
with the same isotope), in contrast to the postreconstruction
camera-specific SBR recovery coefficients, which are appli-
cable to the SBR in FP-CIT SPECT only. Nevertheless,
camera-specific SBR recovery coefficients might allow fur-
ther reduction in unexplained SBR variance.
We hypothesize that the reduction in intersubject variability
with QSPECT is also related to more homogeneous back-
ground binding across the whole brain (Fig. 3), which reduces
intersubject variability of the nonspecific count concentration
CR. Homogenous background activity also simplifies visual
interpretation of the SPECT images by improved anatomical
delineation of the brain.
‘Fading out’ of nonspecific FP-CIT binding towards the
edges of the brain with LINK and HERMES might also have
resulted in underestimation of mean FP-CIT binding in whole
brain (without striata) as the reference value, which in turn
would explain why striatal SBR was on average about 25 %
higher with LINK and HERMES than with QSPECT. The
25 % difference between QSPECT and LINK/HERMES
SBR appears surprisingly large at first sight, particularly con-
sidering that both QSPECT (Fig. 2) and LINK [15] accurately
reproduced the true SBR in a realistic, i.e. anthropomorphic,
striatal phantom. To some extent this might be explained by
the sensitivity of the Southampton method with respect to
variation of CR. The latter is associated with the large size of
the striatum ROI typically used with the Southampton method
to make sure that all striatal counts are collected in each indi-
vidual subject. This can be seen as follows. The total tracer
binding T in the (generous) striatum ROI can be written as the
sum of striatal and extrastriatal counts:
T ¼ V 0S*CS þ V−V
0
S
 
*C
0
R ð3Þ
where VS′ is the actual volume of the striatum (that could be
different from VS), CS is the FP-CIT concentration in the stri-
atum, and CR′ is the (nondisplaceable) FP-CIT concentration
in extrastriatal voxels within the striatum ROI (that could be
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different from CR). Inserting Eq. 3 into the definition of the
Southampton SBR according to Eqs.. 1 and 2 results in:
SBR ¼ V
0
S
V S
*
CS−C
0
R
CR
þ V
VS
*
C
0
R−CR
CR
ð4Þ
If VS′=VS and CR′=CR, the first term in Eq. 4 is the true SBR,
and the second term vanishes. If CR slightly underestimates
CR′, the first term is still a good approximation of the actual
SBR. However, the second term becomes rather large, that is
due to the amplification factor V/VS=127.6 ml/11.2 ml=11.4.
For example, in case of 10 % underestimation of CR′
(CR=0.9 × CR′), the second term computes to 1.3, i.e. SBR
is overestimated by 1.3. For true SBR=7, this accounts for an
overestimation by 19 %. Thus, the difference in SBR
observed between QSPECT and LINK/HERMES might
be explained by a difference in CR of about 10 %. This
rather small difference might be explained by some extra
factors when moving from a striatal phantom to patients,
e.g. contribution of activity from distant body parts to
scatter and septal penetration, for which QSPECT and
LINK/HERMES correct differently.
According to Eq. 4, variation in CR has an even bigger
effect in cases of poor specific binding. For example, the rel-
ative SBR change caused by a 10 % CR difference increases
from 19% for true SBR=7, to 33% for true SBR=4, to 65%
for true SBR=2, to 130% for true SBR=1. Yet this effect was
not observed in the human data in this study: the percentage
SBR difference between QSPECT and LINK/HERMES was
more or less independent of the SBR (Fig. 4, right column).
However, the ENC-DAT subjects cover only the range
SBR≥7 (Fig. 5) at which the CR dependence of the SBR is
rather flat. Studies including patients with reduced SBR are
required to test whether the percentage difference between
QSPECT and LINK/HERMES SBR increases with decreas-
ing SBR which then would support the hypothesis that the
SBR difference between QSPECT and LINK/HERMES is
due to differences in the CR estimate.
It is important to note that the CR-mediated impact of the
reconstruction method on SBR depends on the reference region,
as was expected: whereas using the whole brain (excluding the
striata) and the occipital lobe resulted in lower SBR with
QSPECT compared to LINK/HERMES, using the cerebellum
resulted in higher SBR with QSPECT (Fig. 4b). Furthermore,
the impact of the ‘fading out’ of nonspecific FP-CIT binding
towards the edges of the brain might be reduced by shrinking
the reference region to avoid ‘fading out’ edges.
The Southampton SBR depends not only on the nonspecif-
ic FP-CIT concentration CR as measured, i.e. an error-prone
quantity, but also on the total activity T in the striatum ROI.
From Eq. 2, which is symmetrical in T and 1/CR, it is evident
that the Southampton SBR is as sensitive to variation in T as it
is to variation in CR.
The secondary aim of this study was to evaluate different
reference regions for estimation of nonspecific FP-CIT bind-
ing with respect to their impact on the random error in the
quantitative analysis. The results demonstrate that the whole
brain without striata outperformed the occipital lobe and cer-
ebellum in this respect. The proportion of variance in the SBR
explained by age was largest with the whole brain, indepen-
dently of the reconstruction method. The requirements for the
reference region in FP-CIT SPECT are that it shows (1) only
very low DAT concentration and (2) the same nonspecific
FP-CIT uptake as the striatum. DAT density is very low in
the cerebellum and all neocortical brain regions [34].
However, very often the reference region is restricted to the
occipital lobe [7, 35] or the cerebellum [8]. This restriction to a
smaller than necessary reference region might result in in-
creased test–retest and intersubject variability of the SBR,
not only due to increased statistical noise in CR secondary to
the lower number of counts (see Eq. 2), but also due to vari-
ability in the identification (delineation) of the reference re-
gion in each individual scan. The results of the present study
suggest that the largest possible reference region for FP-CIT
SPECT, the whole brain without striata, indeed stabilizes
quantitative analysis. This is in agreement with recent findings
byKupitz et al. who compared the whole brain (without striata
and the predominantly SERT-binding regions thalamus and
brainstem) as the reference region in FP-CIT SPECT to the
frontal and occipital lobes [36]. The use of the whole brain
resulted in the highest area under the ROC curve of the SBR
for differentiation between neurodegenerative and
nonneurodegenerative parkinsonian syndrome. Whole brain
without striata as reference region for FP-CIT SPECTwas first
proposed by Tossici-Bolt et al. who used a 44-mm thick
transaxial slice centred at the highest striatal FP-CIT binding
for quantitative analyses [11].
The whole-brain (without striata) reference region includes
the cerebrospinal fluid (CSF) space of the lateral and third
ventricle and some interhemispheric voxels (although the
frontal horn of the lateral ventricle and third ventricle are ex-
cluded to a large extent in most patients due to the large stri-
atum ROI used with the Southampton method; Fig. 1). This
might limit the use of the whole brain as reference region in
clinical patient care, since the CSF space can be strongly di-
lated in patients. However, the contribution of non-greymatter
voxels might be reduced by using the 75th percentile of the
voxel intensities in the whole-brain ROI rather than the mean
to characterize nonspecific tracer binding [36]. The 75th per-
centile excludes CSF voxels, and, assuming tracer uptake to
be higher in cortical grey matter than in white matter, it is also
more representative of grey than of white matter. Finally, the
75th percentile might also account for lesions such as stroke,
since even a large stroke probably alters the distribution of
voxel intensities only below the 75th percentile so that the
75th percentile is not affected. The whole-brain (without
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striata) reference region also includes white matter. This might
appear a further limitation at first sight, but the ‘big’ striatum
ROIs typically used with the Southampton method might con-
tain about as much white matter as grey matter. Thus, a refer-
ence region comprising a similar mixture of white and grey
matter might bemore appropriate than a pure greymatter ROI.
However, in practice this is probably not relevant, because
FP-CIT uptake is very similar in cortical grey matter and white
matter.
Concerning the cerebellum as reference region, it must be
stated that in some patients (with hunched shoulders) it is
difficult to achieve a small radius of rotation of the detectors
if the cerebellum is to be included within the field of view. In
these patients, spatial resolution (which requires a small rota-
tion radius) is preferred over cerebellar acquisition. This in-
validates the cerebellum as reference region to some extent,
since it is strongly recommended that the same reference re-
gion be used in all subjects.
This study did not compare the reconstruction methods
with respect to their impact on spatial resolution. At first sight,
this appears relevant in the context of noise reduction by
QSPECT, since noise reduction might be achieved by degra-
dation of spatial resolution. There is indeed some smoothing
inherent both in the geometric averaging of opposite projec-
tions and in the convolution associated with the TDSC scatter
correction used byQSPECT. The number of OSEM iterations/
subsets as well as the kernel used for postfiltering also have an
effect on spatial resolution. In LINK and HERMES, OSEM
was applied with 10 iterations/10 subsets and 12 iterations/8
subsets for raw data with 120 and 128 projections, respective-
ly, so that the effective number of maximum likelihood expec-
tation maximization (MLEM) iterations was about 100 (num-
ber of iterations times number of subsets). In QSPECT, OSEM
was applied with 4 iterations/8 subsets, so that the effective
number of MLEM iterations appears considerably lower,
which might indicate ‘under-iteration’ with QSPECT.
However, correction for scatter (and septal penetration) with
QSPECT results in a scatter-free GM of opposing projections
and therefore halves the number of projections prior to recon-
struction. This, according to our experience, speeds up the
convergence of iterative reconstruction by a factor of more
than 2. Thus, the effective number of MLEM iterations of
QSPECT with 4 iterations and 8 subsets of GM projections
is probably rather close to 100, i.e. similar to LINK and
HERMES. This assumption is supported by the fact that the
striatal SBR computed from QSPECT images reconstructed
with 8 subsets reaches a plateau at about 4 iterations, i.e.
additional iterations do not change the SBR (results not
shown).
Postfiltering had a large impact on the visual appearance of
SPECT images, but its effect on striatal SBR was negligible.
This is because SBR was computed according to the
Southampton method, which was specifically designed to
eliminate the impact of spatial resolution [31]. Therefore, the
results and conclusions of the present study were most likely
not affected by possible differences in spatial resolution be-
tween the tested reconstruction algorithms.
Finally, ROIs for the quantitative analysis were placed
manually in this study. It is possible to embed ROI definition
in software for fully automated quantitative analysis of FP-
CIT SPECT. However, the Southampton method uses large
ROIs (Fig. 1), in contrast to conventional methods that use
small ROIs which are intended to precisely delineate the ana-
tomical structure of the striatum. Therefore, the Southampton
method is less sensitive to the limitations of manual ROI
placement.
In conclusion, both image reconstruction and the reference
region have a considerable impact on intersubject variability
of quantitative estimates of striatal DATavailability in FP-CIT
SPECT. Among the tested software packages (all with correc-
tion for scatter and septal penetration, iterative Chang attenu-
ation correction and OSEM reconstruction), QSPECT provid-
ed the lowest intersubject variability of the specific striatal FP-
CIT binding ratio in healthy subjects from the ENC-DAT.
Concerning the reference region, the whole brain excluding
striata resulted in more stable results than either the occipital
lobe or cerebellum, independent of the reconstruction algo-
rithm, and therefore might be recommended as the reference
region in FP-CIT SPECT.
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